StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultAug 6, 2026, 07:12 AM

Zoetis Q2 Revenue Flat at $2.5B; Full-Year Guidance Cut

AI Summary

Zoetis Inc. reported flat revenue of $2.5 billion for the second quarter of 2026, with reported net income decreasing 5% to $691 million. Adjusted diluted EPS increased 5% to $1.87. The company revised its full-year 2026 revenue guidance downwards to $9.12 billion - $9.32 billion, citing a pressured Companion Animal market and heightened competition. Full-year adjusted diluted EPS guidance was also lowered to $6.15 - $6.25.

Key Highlights

  • Q2 2026 Revenue was $2.5 billion, flat reported and down 1% on an organic operational basis.
  • Q2 2026 Net Income was $691 million, a 5% decrease reported, with diluted EPS of $1.65, up 1% reported.
  • Q2 2026 Adjusted Net Income was $781 million, down 1% reported, with adjusted diluted EPS of $1.87, up 5% reported.
  • Full-year 2026 Revenue Guidance revised to $9.12 billion - $9.32 billion, representing (3)% to (1)% organic operational growth.
  • Full-year 2026 Adjusted Diluted EPS Guidance revised to $6.15 - $6.25.
  • U.S. segment revenue decreased 7% due to softer companion animal demand and heightened competition.
  • International segment revenue increased 8% reported and 6% on an organic operational basis.
  • Livestock product sales grew 12% reported and 11% on an organic operational basis.